Drugs & TargetsFree Alimta + Keytruda and platinum chemo for NSCLC gets FDA label expansion February 01, 2019Vol.45 No.05
Drugs & TargetsFree Trovagene and PoC Capital agree to fund clinical development of onvansertib in metastatic colorectal cancer February 01, 2019Vol.45 No.05
Clinical RoundupFree Study incorporates patient feedback into better cancer treatments February 01, 2019Vol.45 No.05
Clinical RoundupFree Patients getting placebo allowed to cross to Erleada as TITAN results unblinded February 01, 2019Vol.45 No.05
Clinical RoundupFree Antioxidants may enhance chemotherapy treatment for brain tumor February 01, 2019Vol.45 No.05
FreeTrials & Tribulations Glioblastoma patient is first to receive treatment under Right to Try. Our question is Why? February 01, 2019Vol.45 No.05By Kelly McBride Folkers and Alison Bateman-House
FreeIn Brief NYU receives anonymous $75M gift to establish center for blood cancers February 01, 2019Vol.45 No.05
FreeIn Brief Ross Mitchell named artificial intelligence officer at Moffitt February 01, 2019Vol.45 No.05
FreeIn Brief Sagar Lonial awarded Gray Family Chair in Cancer at Winship February 01, 2019Vol.45 No.05